Let's spread the word about Immunotherapy! Click to share this page with your community.

CIM20 Twitter Takeover with @timisstuck

On Friday, June 26, Timothy Fessenden, Ph.D., a CRI Postdoctoral Fellow at the Massachusetts Institute of Technology, will take over the Cancer Research Institute Twitter account (@CancerResearch) and share a day in the life of a scientist.

Dr. Fessenden, who regularly tweets from @timisstuck, is using novel imaging approaches to define how the actomyosin cell “skeleton” enables dendritic cells to carry out their highly specialized functions during the sensing and elimination of tumors.

Follow Dr. Fessenden on Twitter and learn about the different tools used in a cancer immunotherapy research lab. Visit our Twitter account @CancerResearch or follow along with the hashtag #CIM20.

*Immunotherapy results may vary from patient to patient.

Top